Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency

Haematologica. 2020 Jul;105(7):e373-e375. doi: 10.3324/haematol.2020.246686. Epub 2020 Apr 9.

Authors

Rawia F G Jensen¹, Morten H Dziegiel^{2

3}, Klaus Rieneck², Henrik Birgens¹, Andreas Glenthøj⁴

Affiliations

¹ Danish Center for Hemoglobinopathies, Department of Hematology, Herlev and Gentofte Hospital, Herlev.
² Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
³ Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
⁴ Danish Center for Hemoglobinopathies, Department of Hematology, Herlev and Gentofte Hospital, Herlev [email protected].

No abstract available

Publication types

Letter

MeSH terms

Adult
Anemia, Hemolytic, Congenital Nonspherocytic* / genetics
Anemia, Hemolytic, Congenital Nonspherocytic* / therapy
Blood Component Removal*
Humans
Pyruvate Kinase / deficiency
Pyruvate Metabolism, Inborn Errors* / genetics
Pyruvate Metabolism, Inborn Errors* / therapy

Substances

Pyruvate Kinase

Supplementary concepts

Pyruvate Kinase Deficiency of Red Cells